Abbott Laboratories (ABT) stands out as a top dividend stock with consistent growth

From Yahoo Finance: 2025-04-07 14:24:00

Abbott Laboratories stands out among profitable dividend stocks. Dividends have become a significant part of personal income, growing from 2.68% in 1980 to 7.88% in 2024. Dividend stocks are gaining renewed interest due to market turbulence and their stable characteristics during rough economic patches.

Analysts like Peramunetilleke predict that dividend stocks will outperform this year, driven by high-quality yield stocks and defensive yield names. The Dividend Aristocrat Index has dropped by over 4% in 2025, but dividend-focused ETFs are seeing growth. Dividend strategies have proven to be defensive plays during market cycles.

Abbott Laboratories, with a net profit margin of 31.95%, is a top dividend stock. The American medical device company reported $11 billion in revenue in Q4 2024, showing consistent growth. Despite missing Wall Street estimates, Abbott Laboratories met its original projections for organic sales growth and earnings per share. They also have a 53-year streak of consistent dividend growth. Some investors believe deeply undervalued dividend stocks offer better returns than ABT. A dirt cheap dividend stock trading at 10 times earnings with double-digit annual growth may be worth considering. Explore this opportunity for potentially higher returns in a shorter time frame. Check out the full report for more details.

Read more: Is Abbott Laboratories (ABT) the Most Profitable Dividend Stock to Buy Now?